The role of interleukin 1 in acute neurodegeneration and stroke: Pathophysiological and therapeutic implications

Journal of Clinical Investigation

Volumn 100, Issue 11, 1997, Pages 2648-2652

  Rothwell, Nancy ^a,b   Allan, Stuart ^a   Toulmond, Sylvie ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b G38 Stopford Building   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

APOPTOSIS; BRAIN DEGENERATION; BRAIN INJURY; BRAIN ISCHEMIA; HUMAN; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0031438499     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119808     Document Type: Review

References (15)

1. Hopkins, S.J., and N.J. Rothwell. 1995. Cytokines in the nervous system. I. Expression and recognition. TINS (Trends Neurosci.). 18:83-88.
2. Nicholson, D.W., and N.A. Thomberry. 1997. Caspases: killer proteases. TIBS (Trends Biochem. Sci.). 22:299-300.
3. Rothwell, N.J. 1997. Neuroimmune interactions: the role of cytokines. Br. J. Pharmacol. 121:841-847.
4. Rothwell, N.J., P. Stroemer, C. Lawrence, and C. Davies. 1996. Actions of IL-1 in neurodegeneration. In Pharmacology of Cerebral Ischaemia. J. Krieglstein, editor. Medpharm, Stuttgart. 125-129.
5. Relton, J.K., and N.J. Rothwell. 1992. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29:43-46.
6. Relton, D., J.K. Relton, G. Miller, A. Bendele, N. Fischer, and D. Russell. 1996. Cytokines as therapeutic agents in neurological disorders. In Cytokines in the Nervous System. N. Rothwell, editor. Chapman and Hall, New York. 163-178.
7. Garcia, J.H., K.-F. Liu, and J.K. Relton. 1995. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Physiol. 147:1477-1486.
8. Loddick, S.A., A. MacKenzie, and N.J. Rothwell. 1996. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. Neuroreport. 7: 1465-1468.
9. Friedlander, R.M., V. Gagliardini, H. Hara, K.B. Fink, W. Li, G. MacDonald, M.C. Dischman, A.H. Greenberg, M.A. Moskowitz, and J. Yuan. 1997. Expression of a dominant negative mutant of interleukin-1β converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185:933-940.
10. Friedlander, R.M., V. Gagliardini, R.J. Rotello, and J. Yuan. 1996. Functional role of interleukin-1β (IL-1β) in IL-1β-converting enzyme-mediated apoptosis. J. Exp. Med. 184:717-724.
11. Strijbos, P.J.L.M., and N.J. Rothwell. 1995. Interleukin-1β attenuates excitatory amino acid induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15:3468-3474.
12. Allan, S.M., C.B. Lawrence, R.I. Grundy, and N.J. Rothwell. 1997. IL-1β and IL-1ra act in the striatum to modify excitotoxic brain damage in the rat. Soc. Neurosci. Abstr. 23:8979.
13. Flower, R.J., and N.J. Rothwell. 1994. Lipocortin-1: cellular mechanisms and clinical relevance. TIPS (Trends Pharmacol. Sci.). 15:71-76.
14. Loddick, S.A., M.-L. Wong, P.B. Bongiorno, P.W. Gold, J. Licinio, and N.J. Rothwell. 1997. Endogenous interleukin-1 receptor antagonist is neuroprotertive. Biochem. Biophys. Res. Commun. 234:211-215.
15. Rothwell, N.J. 1996. Cytokines in Alzheimer's and other neurodegenerative diseases. In Alzheimer's Disease. Ernst Schering Research Foundation Worshop. J.D. Turner, K. Beyreuther, and F. Theuring, editors. Springer-Verlag, Berlin. 127-146.